Maravai Lifesciences Holdings Inc (MRVI) stock saw a decline, ending the day at $5.5 which represents a decrease of $-0.11 or -1.96% from the prior close of $5.61. The stock opened at $5.79 and ...
Maravai LifeSciences (MRVI) announced its acquisition of intellectual property and relevant assets from Molecular Assemblies, or MAI. The ...
EST Maravai Lifesciences (MRVI) jumps 6% to $5.85 after MAI IP acquisition announcementInvest with Confidence: Follow TipRanks' Top Wall ...
Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Zacks.com on MSN1d
Revvity Gears Up for Q4 Earnings: What's in the Offing?Revvity, Inc. RVTY is slated to report fourth-quarter 2024 results on Jan. 31, before market open. In the last reported ...
SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...
Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...
As of January 22 at 10:26:03 AM EST. Market Open.
1 Day MRVI -8.55% DJIA -0.31% S&P Mid Cap 400 -0.41% Health Care/Life Sciences 0.39% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback